Home ›
Entities
› academia
› A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A
Research article (The Journal of Clinical Pharmacology, 2021) · cited 12× · AI/ML
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A
Summary
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia An is a scholarly article[1].
Key Facts
A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A. Retrieved May 24, 2026, from https://4ort.xyz/entity/a-modelbased-framework-to-inform-the-dose-selection-and-study-design-of-emicizumab-for-pediatric-patients-with-hemophili
MLA“A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/a-modelbased-framework-to-inform-the-dose-selection-and-study-design-of-emicizumab-for-pediatric-patients-with-hemophili.
BibTeX@misc{4ortxyz_a-modelbased-framework-to-inform-the-dose-selection-and-study-design-of-emicizumab-for-pediatric-patients-with-hemophili_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A}}, year = {2026}, url = {https://4ort.xyz/entity/a-modelbased-framework-to-inform-the-dose-selection-and-study-design-of-emicizumab-for-pediatric-patients-with-hemophili}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): A Model‐Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A — https://4ort.xyz/entity/a-modelbased-framework-to-inform-the-dose-selection-and-study-design-of-emicizumab-for-pediatric-patients-with-hemophili (retrieved 2026-05-24)
